Webinar Replay: Revolutionizing Skin Cancer Detection with SkinBit

In this webinar, the SkinBit founding team shared their mission to make early skin cancer detection fast, accessible, and data-driven. They presented SkinBit’s groundbreaking AI-powered dermoscopic imaging platform, which captures full-body scans in under 60 seconds and assesses malignancy risk without needing a biopsy.

We covered:

• The urgent need for innovation in dermatology

• Our unique technology and data advantages

• Go-to-market strategy, pricing, and early traction

• Vision for national clinic expansion and FDA pathway

SkinBit is creating the world’s first scalable skin screening platform — delivering medical-grade scans at consumer points of care like MedSpas, imaging centers, and preventive clinics. With strong early demand and a clear revenue path, we’re inviting investors to join us on this journey to democratize skin cancer prevention.